zoledronic acid sandoz 5 mg/100 ml infusionsvätska, lösning
sandoz a/s - zoledronsyramonohydrat - infusionsvätska, lösning - 5 mg/100 ml - zoledronsyramonohydrat 5,33 mg aktiv substans; mannitol hjälpämne - zoledronsyra
sitagliptin accord
accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
sugammadex vocate 100 mg/ml injektionsvätska, lösning
vocate pharmaceuticals s.a. - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108,8 mg aktiv substans
sugammadex bioglan 100 mg/ml injektionsvätska, lösning
bioglan ab - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108,8 mg aktiv substans
sugammadex orion 100 mg/ml injektionsvätska, lösning
orion corporation - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108,8 mg aktiv substans
sugammadex kalceks 100 mg/ml injektionsvätska, lösning
as kalceks - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108,8 mg aktiv substans
sugammadex panpharma 100 mg/ml injektionsvätska, lösning
panpharma - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108,8 mg aktiv substans
sugammadex atnahs 100 mg/ml injektionsvätska, lösning
atnahs pharma netherlands b.v. - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108 mg aktiv substans
sugammadex aguettant 10 mg/ml injektionsvätska, lösning i förfylld spruta
laboratoire aguettant - sugammadexnatrium - injektionsvätska, lösning i förfylld spruta - 10 mg/ml - sugammadexnatrium 10,88 mg aktiv substans
sugammadex aguettant 50 mg/ml injektionsvätska, lösning i förfylld spruta
laboratoire aguettant - sugammadexnatrium - injektionsvätska, lösning i förfylld spruta - 50 mg/ml - sugammadexnatrium 54,4 mg aktiv substans